Ghana vs Hong Kong: The number of people with susceptibility test result for rifampicin
Ghana
96.1
in 2021
Hong Kong
94.83
in 2021
Ghana rank
49th
Hong Kong rank
52nd
The number of people with susceptibility test result for rifampicin over time
- Ghana
- Hong Kong
How they compare
Ghana currently reports 96.1 against 94.83 in Hong Kong, a difference of 1.27.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Hong Kong ahead.
Ghana ranks 49th and Hong Kong ranks 52nd of 146 countries.
Ghana has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Ghana | Hong Kong | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 97.71 | 96.18 | 1.53 | Ghana |
| 2020s | 98.05 | 94.72 | 3.33 | Ghana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Ghana or Hong Kong?
- Ghana, at 96.1 against 94.83 in Hong Kong as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Ghana and Hong Kong?
- 1.27, with Ghana ahead.
- How many years of comparable data are there for Ghana and Hong Kong?
- 5 years are reported by both, from 2017 to 2021.
- How do Ghana and Hong Kong rank globally for the number of people with susceptibility test result for rifampicin?
- Ghana ranks 49th and Hong Kong ranks 52nd of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.